MMP9 and rheumatoid arthritis: Earlier investigations have proposed that Icariin, the active individual component of flavonoid glycosides derived from Epimedium grandiflorum, may alleviate RA by suppressing the expression of MMP9, a marker for osteoclasts, lowering Th17 cell counts, and impeding the activation of STAT3, thereby reducing the production of IL-1745.